Destroying cancer-causing RNA could lead to bespoke treatments, say scientists
Peter Mac researchers have taken the first step towards designing rapid personalized cancer treatments by 'cutting out' disease-causing RNA.
Jul 2, 2024
0
42
Peter Mac researchers have taken the first step towards designing rapid personalized cancer treatments by 'cutting out' disease-causing RNA.
Jul 2, 2024
0
42
Researchers show for the first time that engineered human plasma B cells can be used to treat a disease—specifically leukemia—in a humanized animal model. The results mark a key step in the realization of ePCs as therapies ...
Jul 2, 2024
0
52
A new study sheds light on a medical question scientists have long wondered: why do 40% of children with the rare neurodevelopmental disorder KBG syndrome have heart defects? The research now points to a critical link between ...
Jul 2, 2024
0
27
In the largest study of its kind, scientists at the University of Warwick have investigated a range of contributing risk factors for suicide—helping to identify individuals who might benefit from interventions.
Jul 2, 2024
0
58
A study led by Pompeu Fabra University describes the mechanism whereby insulinomas, a rare type of neuroendocrine tumor that affects pancreatic beta cells, form. According to the study, insulinomas are the result of the accumulation ...
Jul 2, 2024
0
26
At the beginning of the COVID-19 pandemic, a group of Brazilian researchers showed why SARS-CoV-2 infection tends to be more severe in diabetic patients. Now, the same team based at the Institute of Biology of the State University ...
Jul 2, 2024
0
2
Imagine being a paramedic treating a trauma patient who's bleeding severely. You know your patient's life is in danger, but there's not much you can do because the patient needs an infusion of blood containing platelets. ...
Jul 2, 2024
0
4
In the fight to beat cancer, scientists have recognized the importance of catching it early.
Jul 2, 2024
0
34
Borstel researchers are the first to develop a biomarker to predict the occurrence of neuropathic adverse events during therapy for multidrug-resistant tuberculosis. The results have now been published in the journal Pathogens ...
Jul 2, 2024
0
0
A new study in mice hints at the promise of an eventual alternative treatment option for the "wet" version of age-related macular degeneration (AMD).
Jul 2, 2024
0
0